Myeloproliferative Neoplasms Specialists in Massachusetts

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

David Kuter, MD DPHIL

Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School

Oncology

Amir Fathi, M.D.

Professor of Medicine, Harvard Medical School; Program Director, Center for Leukemia, Massachusetts General Hospital

Hematology

Marlise Luskin, M.D.

Assistant Professor of Medicine, Harvard Medical School; Senior Physician, Dana-Farber Cancer Institute; Educational Director, Adult Leukemia Program, Dana-Farber Cancer Institute; Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program

Oncology

Gabriela Hobbs, MD

Hematology

Robert Lindsley, MD, PHD

Associate Professor of Medicine, Harvard Medical School; Director, Edward P. Evans Center for Myelodysplastic Syndrome; Director of Clinical Genomics in Hematologic Malignancies

Oncology

Martha Wadleigh, MD

Director, Inpatient Oncology; Assistant Professor of Medicine, Harvard Medical School

Oncology

Richard Stone, D.C.

Director of the Adult Acute Leukemia Program at DFCI, serves on the Medical Oncology Board of the American Board of Internal Medicine, and is vice chair of th; Chief of Staff

Hematology

Katayoon Goodarzi, M.D.

Hematology

Rupa Narayan, MD

Hematology

Antonio Giordano, M.D., PH.D

Clinical Director, Center for Cancer Therapeutic Innovation; Breast Cancer Pathways Medical Director, Dana-Farber Cancer Institute

Hematology

Chi-Joan How, MD

Clinical Chief of Hematology, Brigham and Women's Faulkner Hospital; Instructor in Medicine, Harvard Medical School

Oncology